Literature DB >> 1087577

Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.

B Korner, H K Jensen.   

Abstract

Prompted by the sensitivity of trichomonads to metronidazole and nifuratel in clinical practice, a study was conducted in 1971-1972 of 63 consecutive strains of Trichomonas vaginalis isolated from women with clinically refractory vaginal discharge. Their susceptibility to metronidazole, tinidazole, and nifuratel was tested, using a serial tube dilution technique. The minimum concentrations which in 48 hrs caused immobilization and lysis of trichomonads cultured in Diamond's medium was assessed. No differences in drug potency could be determined. The median trichomonistatic and trichomonicidal concentrations were 0-1 and 0-6 mug/ml. respectively when using an inoculum of 10,000 organisms per ml. An inoculum of 100,000 per ml. resulted in inhibitory concentrations of 1-0 and killing concentrations of 3-3 mug./ml. These levels are readily attained in blood and vaginal tissue after oral ingestion of the two imidazole derivatives. Thus, metronidazole has maintained its efficacy since it was first introduced more than a decade ago. The few therapeutic failures with metronidazole and tinidazole are considered to have been caused by pharmacokinetic deficiencies in the patients, or by re-infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087577      PMCID: PMC1045320          DOI: 10.1136/sti.52.6.404

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  25 in total

1.  [BIOLOGICAL PROPERTIES OF N-(5-NITRO-2-FURFURYLIDENE)-3-AMINO-5-METHYLMERCAPTOMETHYL-2-OXAZOLIDINONE].

Authors:  R SCURI; L FAILLA
Journal:  Farmaco Sci       Date:  1964-04

2.  Metronidazole treatment of trichomoniasis in the female. Report of an extended trial.

Authors:  L WATT; R F JENNISON
Journal:  Br Med J       Date:  1962-02-03

3.  Strain sensitivity of Trichomonas vaginalis to metronidazole.

Authors:  S SQUIRES; J A McFADZEAN
Journal:  Br J Vener Dis       Date:  1962-12

4.  Laboratory studies with the systemic trichomonacide, metronidazole.

Authors:  R F JENNISON; P STENTON; L WATT
Journal:  J Clin Pathol       Date:  1961-07       Impact factor: 3.411

5.  [The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].

Authors:  C COSAR; L JULOU
Journal:  Ann Inst Pasteur (Paris)       Date:  1959-02

6.  Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration.

Authors:  P O KANE; J A McFADZEAN; S SQUIRES; A J KING; C S NICOL
Journal:  Br J Vener Dis       Date:  1961-12

7.  The antitrichomonal activity of amidonitrothiazoles.

Authors:  S R BUSHBY; F C COPP
Journal:  J Pharm Pharmacol       Date:  1955-02       Impact factor: 3.765

8.  Further observations on strain sensitivity of Trichomonas vaginalis to metronidazole.

Authors:  J A McFadzean; I M Pugh; S L Squires; J P Whelan
Journal:  Br J Vener Dis       Date:  1969-06

9.  Tinidazole, a new antiprotozoal agent: Effect on Trichomonas and other protozoa.

Authors:  H L Howes; J E Lynch; J L Kivlin
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

10.  Tinidazole and metronidazole pharmocokinetics in man and mouse.

Authors:  J A Taylor; J R Migliardi; M S Von Wittenau
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969
View more
  11 in total

1.  Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain.

Authors:  S Krajden; J G Lossick; E Wilk; J Yang; J S Keystone; K Elliott
Journal:  CMAJ       Date:  1986-06-15       Impact factor: 8.262

2.  Studies on strain sensitivity of Trichomonas vaginalis to metronidazole.

Authors:  J G Meingassner; L Havelec; H Mieth
Journal:  Br J Vener Dis       Date:  1978-04

3.  Secnidazole. A 5-nitroimidazole derivative with a long half-life.

Authors:  D Videau; G Niel; A Siboulet; F Catalan
Journal:  Br J Vener Dis       Date:  1978-04

4.  Inhibition of Tritrichomonas foetus by vermiculine in vitro.

Authors:  A Fusková; J Fuska; M Kettner
Journal:  Folia Microbiol (Praha)       Date:  1978       Impact factor: 2.099

5.  Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.

Authors:  J G Meingassner; J Thurner
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

6.  Metronidazole-resistant Trichomonas vaginalis.

Authors:  A Forsgren; L Forssman
Journal:  Br J Vener Dis       Date:  1979-10

Review 7.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

8.  Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.

Authors:  J Kulda; M Vojtĕchovská; J Tachezy; P Demes; E Kunzová
Journal:  Br J Vener Dis       Date:  1982-12

9.  Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.

Authors:  R Scott McClelland; Barbra A Richardson; Wisal M Hassan; Vrasha Chohan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Walter Jaoko; Jeckoniah O Ndinya-Achola; Jared M Baeten; Ann E Kurth; King K Holmes
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

Review 10.  How suitable are available pharmaceuticals for the treatment of sexually transmitted diseases? 1: Conditions presenting as genital discharges.

Authors:  R R Willcox
Journal:  Br J Vener Dis       Date:  1977-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.